Liquidia Corp — Director's Dealing 2023

Dec 19, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Liquidia Corp (LQDA)
CIK: 0001819576
Period of Report: 2023-12-15

Reporting Person: Saggar Rajeev (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-18	Common Stock	S	14887	$7.42	Acquired	164099	Direct

Footnotes

F1: On July 18, 2022, the Reporting Person was awarded an aggregate of 93,834 restricted stock units ("RSUs"), all of which, including the unvested portion, were reported on a Form 4 filed on July 20, 2022. The vesting of 52,782 of those previously reported RSUs was deferred until December 14, 2023. As reported on this Form 4, only the requisite amount of shares were sold to cover the required taxes in connection with the vesting and settlement of the 52,782 previously reported RSUs.

F2: Includes (i) 93,384 RSUs granted to the Reporting Person on July 18, 2022, of which 52,782 have vested as of the date of this Form 4, (ii) 83,333 RSUs granted to the Reporting Person on January 11, 2023, none of which have vested as of the date of this Form 4 and (iii) 1,819 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan on August 31, 2023.